HBM (Lux) Funds - HBM Global Biotechnology Fund A Fonds
120,63
EUR
-6,92
EUR
-5,43
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,78% |
| argenx SE ADR | US04016X1019 | 4,43% |
| Revolution Medicines Inc Ordinary Shares | US76155X1000 | 4,20% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,19% |
| Amgen Inc | US0311621009 | 4,14% |
| United Therapeutics Corp | US91307C1027 | 4,11% |
| Gilead Sciences Inc | US3755581036 | 3,88% |
| Axsome Therapeutics Inc | US05464T1043 | 3,85% |
| Madrigal Pharmaceuticals Inc | US5588681057 | 3,68% |
| Genmab AS | DK0010272202 | 3,36% |
| Sonstige | 59,37% |